Table II. Univariate analyses comparing patients with according to functional outcome mortality at 3-month follow-up.
|
|
mRS 0-2
(n = 378)
|
mRS 3-6
(n = 279)
|
p-value
|
Demographic and clinical characteristics
|
Age (years), median (IQR)
|
73 (62-81)
|
80 (74-85)
|
<0.001
|
Male sex, n (%)
|
176 (46.6%)
|
110 (39.4%)
|
0.068
|
Smoking, n (%)
|
69 (18.3%)
|
24 (8.6%)
|
<0.001
|
Diabetes mellitus, n (%)
|
98 (25.9%)
|
102 (36.6%)
|
0.003
|
Hypertension, n (%)
|
261 (69%)
|
207 (74.2%)
|
0.15
|
Dyslipidemia, n (%)
|
193 (51.1%)
|
151 (54.1%)
|
0.437
|
HbA1c, %, median (IQR)
|
5.8 (5.4-6.2)
|
5.9 (5.6-6.6)
|
<0.001
|
NIHSS on admission, mean ± SD
|
13.4 ± 5.7
|
16.6 ± 4.9
|
<0.001
|
ASPECTS, mean ± SD
|
8.4 ± 1.4
|
7.8 ± 1.5
|
<0.001
|
Occlusion site
|
ICA, n (%)
|
75 (19.8%)
|
79 (28.3%)
|
0.011
|
M1, n (%)
|
214 (56.6%)
|
143 (51.3%)
|
0.173
|
M2, n (%)
|
89 (23.5%)
|
57 (20.4%)
|
0.342
|
Parameters at hospital admission
|
Blood glucose on admission, mg/dL, median (IQR)
|
120 (105-143)
|
136 (112-178)
|
<0.001
|
SBP, mmHg, median (IQR)
|
145 (127-160)
|
149 (128-168)
|
0.073
|
DBP, mmHg, median (IQR)
|
78 (66-86)
|
80 (70-93)
|
0.015
|
Parameters related to treatment
|
IVT, n (%)
|
213 (56.3%)
|
128 (45.9%)
|
0.008
|
ORT, minutes, median (IQR)
|
285 (215-389)
|
320 (250-421)
|
0.003
|
mTICI ≥ 2b. n (%)
|
369 (97.6%)
|
239 (85.7%)
|
<0.001
|
Outcomes
|
NIHSS 24 hours post MT, median (IQR)
|
4 (2-7)
|
14 (8-18)
|
<0.001
|
sICH, n (%)
|
1 (0.3%)
|
16 (5.7%)
|
<0.001
|
Stroke etiology
|
Cardioembolic source, n (%)
|
189 (50.0%)
|
178 (63.8%)
|
<0.001
|
Large vessel disease, n (%)
|
63 (16.7%)
|
28 (10%)
|
0.015
|
Unknown, n (%)
|
106 (28%)
|
68 (24.4%)
|
0.292
|
Other determined, n (%)
|
20 (5.3%)
|
5 (1.8%)
|
0.021
|
Parameters related to glycemia
|
Number of blood glucose measurements, median (IQR)
|
6 (6-9)
|
7 (6-9)
|
0.171
|
GV, SD, mg/dL, median (IQR)
|
15.11 (9.26-25.15)
|
17.91 (11.94-30.37)
|
<0.001
|
GV, coefficient of variation, mg/dL, median (IQR)
|
13.45 (8.59-20.13)
|
14.09 (10.14-22.04)
|
0.134
|
Mean blood glucose, mg/dL, median (IQR)
|
112 (101-126)
|
128 (151-113)
|
<0.001
|
Median blood glucose, mg/dL, median (IQR)
|
109 (98-123)
|
126 (110-148)
|
<0.001
|
Minimum blood glucose, mg/dL, median (IQR)
|
96 (87-106)
|
108 (95-121)
|
<0.001
|
Maximum blood glucose, mg/dL, median (IQR)
|
134 (116-163)
|
157 (131-187)
|
<0.001
|
Demographic and clinical characteristics
|
Age (years), median (IQR)
|
76 (65-82)
|
81 (74-86)
|
<0.001
|
Male sex, n (%)
|
242 (43.2%)
|
44 (45.4%)
|
0.694
|
Smoking, n (%)
|
83 (14.8%)
|
10 (10.3%)
|
0.239
|
Diabetes mellitus, n (%)
|
161 (28.7%)
|
39 (40.2%)
|
0.024
|
Hypertension, n (%)
|
401 (71.6%)
|
67 (69.1%)
|
0.611
|
Dyslipidemia, n (%)
|
295 (52.7%)
|
49 (50.5%)
|
0.694
|
HbA1c, %, median (IQR)
|
5.8 (5.5-6.3)
|
6.1 (5.6-6.8)
|
0.005
|
NIHSS on admission, mean ± SD
|
14.3 ± 5.6
|
17.1 ± 5.2
|
<0.001
|
ASPECTS, mean ± SD
|
8.2 ± 1.4
|
7.8 ± 1.6
|
0.054
|
Occlusion site
|
ICA, n (%)
|
125 (22.3%)
|
29 (29.9%)
|
0.104
|
M1, n (%)
|
306 (54.6%)
|
51 (52.6%)
|
0.706
|
M2, n (%)
|
129 (23%)
|
17 (17.5%)
|
0.228
|
Parameters at hospital admission
|
Blood glucose on admission, mg/dL, median (IQR)
|
122 (108-153)
|
146 (118-180)
|
<0.001
|
SBP, mmHg, median (IQR)
|
147 (128-162)
|
141.5 (127-175)
|
0.624
|
DBP, mmHg, median (IQR)
|
79 (67-90)
|
80.5 (69-86)
|
0.978
|
Parameters related to treatment
|
IVT, n (%)
|
309 (55.2%)
|
32 (33%)
|
<0.001
|
ORT, minutes, median (IQR)
|
292 (226-394)
|
332 (266-448)
|
0.016
|
mTICI ≥ 2b. n (%)
|
529 (94.5%)
|
79 (81.4%)
|
<0.001
|
Outcomes
|
NIHSS 24 hours post MT, median (IQR)
|
6 (2-11)
|
16 (9-19.75)
|
<0.001
|
sICH, n (%)
|
5 (0.9%)
|
12 (12.4%)
|
<0.001
|
Stroke etiology
|
Cardioembolic source, n (%)
|
305 (54.5%)
|
62 (63.9%)
|
0.083
|
Large vessel disease, n (%)
|
83 (14.8%)
|
8 (8.2%)
|
0.084
|
Unknown, n (%)
|
148 (26.4%)
|
26 (26.8%)
|
0.938
|
Other determined, n (%)
|
24 (4.3%)
|
1 (1%)
|
0.155
|
Parameters related to glycemia
|
Number of blood glucose measurements, median (IQR)
|
7 (6-9)
|
7 (6-9)
|
0.997
|
GV, SD, mg/dL, median (IQR)
|
16 (10.02-25.4)
|
23.96 (12.94-37.83)
|
<0.001
|
GV, coefficient of variation, mg/dL, median (IQR)
|
13.32 (8.96-20.01)
|
16.15 (11.34-26.25)
|
0.002
|
Mean blood glucose, mg/dL, median (IQR)
|
117 (103-135)
|
134 (117-160)
|
<0.001
|
Median blood glucose, mg/dL, median (IQR)
|
113 (101-132)
|
130 (112-158)
|
<0.001
|
Minimum blood glucose, mg/dL, median (IQR)
|
98 (88-112)
|
106 (95-122)
|
<0.001
|
Maximum blood glucose, mg/dL, median (IQR)
|
140 (121-169)
|
166 (138-204)
|
<0.001
|
ASPECTS: Alberta Stroke Program Early CT Score; DBP: diastolic blood pressure; GV: glycemic variability; HbA1c: glycated hemoglobin A1c; ICA: internal carotid artery; IQR: interquartile range; IVT: intravenous thrombolysis; mRS: modified Ranking scale; mTICI: modified thrombolysis in cerebral infarction scale; NIHSS: National Institutes of Health Stroke Scale; ORT: onset to recanalization time; SBP: systolic blood pressure; SD: standard deviation; sICH: symptomatic ICH.
|